On this page
- What guidelines are and why they matter
- European ESC guidelines: choosing the test by likelihood of disease
- UK NICE recommendations: CT as the first step for most
- What evidence the recommendations are based on
- Where the guidelines agree and where they differ
- What the guidelines mean for you
- Summary
- Frequently asked questions
Guidelines from the ESC, the European Society of Cardiology, and the UK’s NICE now place CT coronary angiography among the first tests for suspected coronary artery disease. The ESC recommends it as a preferred first test when the likelihood of disease is low to moderate, while NICE offers it as the first test to most patients with stable chest pain that may come from the heart. The differences lie more in how patients are selected than in how the method itself is rated.
What guidelines are and why they matter
Clinical guidelines are recommendations written by expert panels based on a review of the available research. They do not dictate what a doctor must do for every patient, but they show which approach has the strongest evidence. Each recommendation carries a class, indicating how confident the experts are that it is beneficial, and a level of evidence, indicating what kind of studies it is based on.
For patients, this means that when a doctor suggests CT coronary angiography, or cardiac CT, the suggestion usually follows an internationally accepted sequence of tests. Guidelines are updated from time to time as new data emerge, so recommendations from ten years ago sometimes differ from today’s. General information about the scan is available in CT coronary angiography: a complete guide.
European ESC guidelines: choosing the test by likelihood of disease
The European guidelines on chronic coronary syndromes, published in 2024, start by estimating how likely it is that a person has narrowed coronary arteries. This is done with a model that, in addition to age, sex and type of symptoms, also considers the number of risk factors, such as smoking, high blood pressure, high cholesterol, diabetes and family history. The estimate can be refined with an ECG, a heart ultrasound and calcification seen on previous scans.
Depending on the resulting likelihood, the guidelines suggest different pathways:
- very low likelihood: further tests can be deferred and attention turned to other possible causes of the symptoms;
- low to moderate likelihood: CT coronary angiography is the preferred test, because it reliably rules out disease and helps assess risk;
- moderate to high likelihood: functional tests are also considered, such as stress echocardiography, myocardial perfusion scintigraphy, PET or cardiac MRI;
- very severe symptoms on minimal exertion: after assessment by a cardiologist, invasive coronary angiography may be performed straight away.
Compared with the previous model, the new one places considerably more people in the very low likelihood group. The aim is to avoid unnecessary tests in those who do not need them and to focus investigation on those who will benefit most. When non-invasive tests do not give a clear answer, the guidelines suggest invasive coronary angiography with flow measurement.
UK NICE recommendations: CT as the first step for most
In 2016, NICE changed its recommendations for investigating recent-onset stable chest pain. Since then, CT coronary angiography has been offered as the first test to patients whose symptoms, based on history and examination, resemble angina, and to those whose pain does not resemble angina but whose ECG suggests possible coronary artery disease.
When the CT result is inconclusive or shows narrowing, a functional test or invasive coronary angiography is suggested as the second step. If, after history and examination, the doctor concludes that the pain is not related to the heart, further cardiac tests are usually not needed.
This approach is simpler than the European one because it does not rely on calculating likelihood, but in practice it has also led to a large increase in the number of CT scans needed. UK professional societies warned from the outset that more scanners and trained doctors would be needed to implement it.
What evidence the recommendations are based on
Large randomised trials played an important role in changing the recommendations. In the UK SCOT-HEART study, patients with stable chest pain who had CT coronary angiography in addition to standard care had fewer deaths from coronary heart disease and non-fatal heart attacks over five years, without a significant increase in invasive coronary angiography or stent procedures. The main explanation is that CT more often detected even mild plaque, so patients started preventive treatment earlier.
The European DISCHARGE study compared an approach starting with CT against going directly to catheterisation in patients with a moderate likelihood of disease. Serious cardiac events were similar in both groups, but there were fewer procedural complications when CT came first. How the two methods compare is covered in CT versus invasive coronary angiography.
Where the guidelines agree and where they differ
The European and UK guidelines, as well as the 2021 American guidelines, agree that CT coronary angiography is a reliable non-invasive test with a place at the start of the investigation of stable symptoms. All three also stress the importance of detecting plaque that does not yet narrow the arteries, because it changes preventive treatment.
The differences concern patient selection. The ESC clearly separates groups by likelihood of disease and, for moderate to high likelihood, gives functional tests equal weight. NICE offers CT to a wider group of people. The American guidelines particularly favour CT in people under 65 without known disease, and more often consider a stress test in older patients. In everyday practice, the choice is also influenced by scanner availability, the centre’s experience and the patient’s own characteristics, such as heart rhythm or kidney function.
For acute chest pain, once a heart attack has been ruled out by blood tests, the American guidelines list CT coronary angiography as a good option for patients at intermediate risk. What this pathway looks like in practice is explained in chest pain: when CT coronary angiography is the right choice.
What the guidelines mean for you
Guidelines help the doctor choose a sensible sequence, but the decision always takes your particular situation into account. It is useful to discuss the following with your doctor:
- how likely, in their assessment, it is that you have coronary artery disease;
- why CT was chosen rather than a functional test or invasive coronary angiography;
- whether anything, such as an irregular rhythm or kidney disease, could affect the scan;
- what will happen depending on whether the result is normal, shows mild plaque or a significant narrowing.
If CT shows a narrowing, the next steps are described in a narrowing was found on CT: what next. Read more about the scan itself on the CT coronary angiography page.
Summary
- The ESC guidelines recommend CT coronary angiography as a preferred first test when the likelihood of coronary artery disease is low to moderate.
- NICE offers it as the first test to most patients with stable chest pain that may come from the heart.
- The recommendations rest on large studies showing benefits for prevention and fewer procedural complications.
- Differences between the guidelines concern patient selection, not the assessment of the method itself.
- If you would like to check whether the scan follows the recommendations for your situation, request a consultation.
Frequently asked questions
Does my doctor have to follow the guidelines?
Not to the letter. Guidelines are evidence-based recommendations, and doctors adapt them to the patient, their other conditions and the tests available.
Why didn’t my doctor suggest CT even though I have chest pain?
They may have judged the likelihood of disease to be very low or, on the contrary, high, making another approach more sensible. Feel free to ask them why.
Do guidelines change often?
Major revisions are published every few years, and the European guidelines on chronic coronary syndromes were last updated in 2024.
Do the guidelines recommend CT for people without symptoms?
These recommendations apply to people with symptoms or suspected disease, not to routine check-ups of healthy people.
The information on this website is for general guidance only and does not replace an examination, diagnosis or advice from a doctor. For decisions about your health, consult your own doctor.

